TBE Seropersistence up to 10 Years After First Booster in Adults

PHASE4CompletedINTERVENTIONAL
Enrollment

243

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Tick-borne Encephalitis (TBE)
Interventions
BIOLOGICAL

FSME-IMMUN 0.5 ml

Solution/suspension for injection (intramuscular injection into the deltoid muscle of the right or left upper arm). Dosage frequency of booster vaccination: dependent on serum TBE antibodies.

Trial Locations (2)

39-200

Prywatny Gabinet Lekarski, Dębica

31-202

"John Paul II Cracow Specialist Hospital, Department of Pediatric Neuroinfections and Neurology", Krakow

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY